Teijin Limited and Hilleman Laboratories have signed a Memorandum of Understanding to establish a strategic international business partnership with the goal of promoting the expansion in contract development and manufacturing organization (CDMO) business in the field of cell and gene therapy. The partnership aims to strengthen support for Japanese customers aiming to expand into the Asia-Pacific region and attract overseas customers from Singapore and surrounding areas to the Japanese market.